← back to search

Jean‐Noël Trochu

Centre National de la Recherche Scientifique · FR
Area of research
Cardiology and Cardiovascular Medicine · Surgery
Research interest
Research interests include Cardiovascular Function and Risk Factors, Heart Failure Treatment and Management, Cardiac Valve Diseases and Treatments, and Cardiac Structural Anomalies and Repair.
h-index
48
citations
11,108
works
277
NIH funding
primary concept
Medicine
email

Recent publications

Echocardiographic Changes With Mavacamten in Nonobstructive Hypertrophic Cardiomyopathy
Journal of the American College of Cardiology 2025cited by 9position: middledoi
Percutaneous Edge-to-Edge Repair for Tricuspid Regurgitation
JACC: Cardiovascular Interventions 2024cited by 45position: middledoi
Aficamten and Cardiopulmonary Exercise Test Performance
JAMA Cardiology 2024cited by 23position: middledoi
Dosing and Safety Profile of Aficamten in Symptomatic Obstructive Hypertrophic Cardiomyopathy: Results From SEQUOIA‐HCM
Journal of the American Heart Association 2024cited by 19position: middledoi
Two-Year Outcomes for Tricuspid Repair With a Transcatheter Edge-to-Edge Valve Repair From the Transatlantic TRILUMINATE Trial
Circulation Cardiovascular Interventions 2023cited by 73position: middledoi
Acute Myocarditis Associated With Desmosomal Gene Variants
JACC Heart Failure 2022cited by 125position: middledoi
Iron deficiency screening is a key issue in chronic inflammatory diseases: A call to action
Journal of Internal Medicine 2022cited by 47position: lastdoi
Towards a Common Definition for the Diagnosis of Iron Deficiency in Chronic Inflammatory Diseases
Nutrients 2022cited by 31position: lastdoi
Genome-wide association analysis in dilated cardiomyopathy reveals two new players in systolic heart failure on chromosomes 3p25.1 and 22q11.23
European Heart Journal 2021cited by 90position: middledoi
Multicentric randomized evaluation of a tricuspid valve percutaneous repair system (clip for the tricuspid valve) in the treatment of severe secondary tricuspid regurgitation Tri.Fr Design paper
European Heart Journal - Cardiovascular Imaging 2021cited by 27position: middledoi
Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial
The Lancet 2020cited by 1,173position: middledoi
Impact of Mitral Regurgitation Severity and Left Ventricular Remodeling on Outcome After MitraClip Implantation
JACC. Cardiovascular imaging 2020cited by 72position: middledoi
Characteristics and Outcome of COAPT-Eligible Patients in the MITRA-FR Trial
Circulation 2020cited by 31position: middledoi
Genome wide association analysis in dilated cardiomyopathy reveals two new key players in systolic heart failure on chromosome 3p25.1 and 22q11.23
bioRxiv (Cold Spring Harbor Laboratory) 2020cited by 2position: middledoi
The continuous heart failure spectrum: moving beyond an ejection fraction classification
European Heart Journal 2019cited by 257position: middledoi
Percutaneous Repair or Medical Treatment for Secondary Mitral Regurgitation: Outcomes at 2 Years
European Journal of Heart Failure 2019cited by 226position: middledoi
Percutaneous Repair or Medical Treatment for Secondary Mitral Regurgitation
New England Journal of Medicine 2018cited by 1,738position: middledoi
Heart failure with reduced ejection fraction
Nature Reviews Disease Primers 2017cited by 224position: middledoi
New insights into mitral valve dystrophy: a Filamin-A genotype–phenotype and outcome study
European Heart Journal 2017cited by 72position: middledoi
Screening for Heart Transplantation and Left Ventricular Assist System: Results from the ScrEEning for Advanced Heart Failure Treatment (SEE-HF) Study
European Journal of Heart Failure 2017cited by 41position: middledoi
Involvement of BAG3 and HSPB7 loci in various etiologies of systolic heart failure: Results of a European collaboration assembling more than 2000 patients
International Journal of Cardiology 2015cited by 25position: middledoi
Current Aspects of the Spectrum of Acute Heart Failure Syndromes in a Real-Life Setting: The OFICA Study
European Journal of Heart Failure 2012cited by 165position: lastdoi

Grants

No grants ingested yet.

Frequent collaborators

Jean‐François Obadia · Hôpital Louis Pradel3 papers (2020–2021)Pascal de Groote · Inserm3 papers (2012–2021)Erwan Donal · German Centre for Cardiovascular Research3 papers (2012–2021)Xavier Armoiry · Université Claude Bernard Lyon 12 papers (2020–2020)Hervé Puy · Centre National de la Recherche Scientifique2 papers (2022–2022)P. Cacoub · Laboratoire National de Référence2 papers (2022–2022)Laurent Peyrin‐Biroulet · Hôpital Lapeyronie2 papers (2022–2022)Valérie Andrieu‐Ponel · Université Claude Bernard Lyon 12 papers (2022–2022)Gabriel Choukroun · University Hospital Frankfurt2 papers (2022–2022)David Messika–Zeitoun · University of Ottawa2 papers (2020–2020)Alec Vahanian · Inserm2 papers (2020–2020)Katell Peoc’h · Université Claude Bernard Lyon 12 papers (2022–2022)Delphine Maucort‐Boulch · Université Claude Bernard Lyon 12 papers (2020–2020)Philipp Lurz · Johannes Gutenberg University Mainz2 papers (2021–2024)Alain Cohen‐Solal · Inserm2 papers (2022–2022) · 2 papers (2022–2022)Florent Boutitie · University Medical Center Hamburg-Eppendorf2 papers (2020–2020)Richard Isnard · Hôpital Charles-Foix2 papers (2012–2015)Patrice Guérin · Université Claude Bernard Lyon 12 papers (2020–2021)Bernard Iung · Istituto di Ricovero e Cura a Carattere Scientifico San Raffaele2 papers (2020–2020)